Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis

• Qingxin Mu ,

  Contributed equally to this work with: Qingxin Mu, Jesse Yu

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft

  Affiliation Department of Pharmaceutics, University of Washington, Seattle, WA, United States of America

  http://orcid.org/0000-0003-4952-6591

  ⨯
• Jesse Yu ,

  Contributed equally to this work with: Qingxin Mu, Jesse Yu

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – review & editing

  Affiliation Department of Pharmaceutics, University of Washington, Seattle, WA, United States of America

  ⨯
• James I. Griffin,

  Roles Investigation, Methodology

  Affiliation Department of Pharmaceutics, University of Washington, Seattle, WA, United States of America

  ⨯
• Yan Wu,

  Roles Investigation

  Current address: Department of Pharmacy, Air Force Medical Center of PLA, Beijing, China

  Affiliation Department of Pharmaceutics, University of Washington, Seattle, WA, United States of America

  ⨯
• Linxi Zhu,

  Roles Investigation, Validation

  Affiliation Department of Pharmaceutics, University of Washington, Seattle, WA, United States of America

  ⨯
• Lisa A. McConnachie,

  Roles Project administration, Writing – review & editing

  Affiliation Department of Pharmaceutics, University of Washington, Seattle, WA, United States of America

  ⨯
• Rodney J. Y. Ho

  Roles Conceptualization, Funding acquisition, Resources, Supervision, Writing – review & editing

  * E-mail: rodneyho@uw.edu

  Affiliations Department of Pharmaceutics, University of Washington, Seattle, WA, United States of America, Department of Bioengineering, University of Washington, Seattle, WA, United States of America

  http://orcid.org/0000-0001-5960-4288

  ⨯